Eric Halioua
(MS, MBA), Chief Executive Officer
President of the Board
e.halioua@pdc-line-pharma.com

http://www.pdc-line-pharma.com
CHU - Tour 5 (B34) – GIGA, Avenue de l'Hôpital 11
4000 LIEGE
Belgium

Eric is a serial entrepreneur that raised more than €100 million over the course of his career and has had numerous successes in the sale and IPO of biotechnology companies. Eric is former CEO of Promethera Biosciences and co-founder of three biotechnology called Myosix (bought by Genzyme mid-2002), Murigenetics and Digital Orthopaedics. Eric worked for 12 years as a Principal in the Healthcare and Life Sciences Practice of Arthur D. Little.  Eric holds two master degrees in Pharmacology and Molecular Biology and a MBA from ESSEC business school (Paris). Eric is as well President of Digital Orthopaedics and Board member of the biotechnology company Bioxodes (Belgium), VitriCell (Belgium) and Innobiochips (France).